Elsevier

Neuropharmacology

Volume 39, Issue 1, January 2000, Pages 75-87
Neuropharmacology

Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways

https://doi.org/10.1016/S0028-3908(99)00106-9Get rights and content

Abstract

We determined the relative effects of chemical receptor inactivation on dopaminergic signaling through adenylate cyclase and phospholipase C pathways and evaluated the behavioral implications of such receptor manipulations. Groups of rats were given intraperitoneal injections of 10 mg/kg N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), a reagent that differentially inactivates neurotransmitter receptors. Control and treated animals were used to assess dopaminergic-mediated behaviors or brain tissues were prepared from the animals and used to assay D1-like receptor binding and agonist-stimulated second messenger formation. EEDQ decreased by 75% the number of D1-like binding sites and completely abolished dopamine-stimulated cyclic AMP formation in striatal membranes. Conversely, dopamine-stimulated phosphoinositide hydrolysis was insensitive to inactivation by EEDQ as examined over different durations of EEDQ treatment, in different brain regions, or with different concentrations of the D1-like receptor agonist SKF38393. EEDQ-pretreated animals lost their stereotypic response to apomorphine but showed increased vacuous jaw movements in response to apomorphine or SKF38393. Basal catalepsy was increased and SCH23390 was unable to further enhance catalepsy beyond the basal levels in the lesioned animals. In naive animals, SCH23390 catalepsy was reversed by apomorphine, and apomorphine stereotypy was reversed by SCH23390. Taken together, the present results imply that the dopamine-sensitive phospholipase C system mediates a subset of dopaminergic behaviors, notably vacuous jaw movements, in contrast to stereotypy and catalepsy which appear to be respectively mediated through stimulation and inhibition of the adenylate cyclase-coupled dopaminergic system.

Introduction

Dopamine mediates diverse behaviors in animals and humans. The physiological actions of dopamine are mediated through at least five subtypes of dopamine receptors, most of which are coupled to the stimulation or inhibition of adenylate cyclase (AC) and consequent modulation of cellular cyclic AMP levels. More recently, substantial evidence has accumulated in support of dopamine receptor coupling to phospholipase C (PLC) leading to the stimulation of phosphoinositide hydrolysis and generation of the second messengers diacylglycerol and inositol phosphate (Felder et al., 1989, Undie and Friedman, 1990, Undie and Friedman, 1992, Martin and Waszczak, 1993, Undie et al., 1994). These dopamine-sensitive AC and PLC systems show differences in regional brain distribution (Undie and Friedman, 1990) and in agonist and antagonist sensitivity (Undie and Friedman, 1992, Undie et al., 1994), suggesting possibly differential roles in dopaminergic physiology and pharmacology. The present study was undertaken as part of our broader efforts at understanding the relative contributions of each dopamine-sensitive signaling cascade to the spectrum of dopaminergic functions and dysfunctions in the brain.

Aminergic receptors can be inactivated to various degrees by the peptide coupling agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Inactivation of brain dopamine D1 or D2 receptors by EEDQ has been associated with decreased receptor binding and changes in various behavioral and biochemical functions in rodents (Meller et al., 1985, Hess et al., 1987, Braestrup and Andersen, 1987, Arnt et al., 1988, Goodale et al., 1988). Not all neurotransmitter receptors are functionally sensitive to EEDQ inactivation, and even within a class of receptors subpopulations of insensitive states have been identified (Rosengarten et al., 1989, Cox and Waszczak, 1990, Rosengarten et al., 1993, Salles et al., 1993, Ogren et al., 1994, Eglen et al., 1994). The primary target of EEDQ reactivity is the carboxylate function which may be present in several amino acid residues of receptor proteins (Garvey et al., 1972, Signorini et al., 1989). Additional factors that may determine the selective susceptibility of receptor proteins to inactivation by EEDQ would include accessibility of EEDQ to the relevant aminoacyl residues on the receptor, and the significance of the susceptible amino acid residues to receptor binding of cognate ligands. Thus, among the D1-like dopamine receptors defined by binding to the specific radioligand [3H]SCH23390, an EEDQ-insensitive subpopulation has been identified (Meller et al., 1985, Rosengarten et al., 1993). Constituting some 20–30% of D1-like binding sites in the rat striatum, these sites have been implicated in dopamine agonist mediation of repetitive or vacuous jaw movements (VJM) in rodents (Rosengarten et al., 1993).

Several studies have indicated that EEDQ treatment causes not only a marked reduction in SCH23390 bindings sites, but also in the ability of dopamine D1-like agonists to stimulate the production of cyclic AMP (Hess et al., 1987, Arnt et al., 1988). Thus, the retention of a dopamine D1-like agonist-elicited behavior in rat brains having compromised dopamine agonist stimulation of cyclic AMP formation, suggests that the postreceptor signaling mechanism involved in mediation of VJM may not be cyclic AMP. To address this hypothesis, we have assessed the elicitation of VJM, catalepsy, and stereotypic behaviors by dopaminergic agents, and measured the numbers and affinities of dopamine D1-like receptors, and D1-like receptor coupling to second messenger systems in naive and EEDQ-treated rats. Consistent with our preliminary findings previously reported (Undie and Cseresnyes, 1996), the present results strongly implicate the dopamine-sensitive PLC-coupled signaling cascade in the dopaminergic mediation of vacuous jaw movements in the rat. The findings further suggest that stereotypy and catalepsy may be opposite behaviors mediated through stimulation and inhibition, respectively, of the dopamine-sensitive AC-mediated signaling system.

Section snippets

Animals and drug treatments

Male Sprague-Dawley rats weighing 225–275g were obtained in several batches from Zivic-Miller Farms (Zelienople, PA). The animals were caged in groups of three and allowed a free supply of food and water except during the time of behavioral testing. Housing temperature was maintained at 21±1°C, and lighting was for 12 h in every 24 h. For EEDQ treatments, animals were randomly assigned to groups and given intraperitoneal injections of EEDQ (10 mg/ml/kg) or vehicle (1 ml/kg). At predetermined

Number and affinity of dopamine D1-like receptor binding sites

Tritiated SCH23390 showed saturable and high specific binding to striatal membrane preparations from vehicle-injected animals, thus indicating the presence of D1-like receptors in this membrane preparation (Fig. 1(A)). Scatchard analysis of the binding data showed that 3 h after in vivo EEDQ treatment the Bmax for [3H]SCH23390 binding was reduced by 78%; the Kd was increased 3-fold but this increase was not statistically significant (Fig. 1(B)). The number of D1-like binding sites remained at

Discussion

The findings of this study suggest that an EEDQ-insensitive subpopulation of dopamine D1-like receptors may couple through PLC to mediate agonist-induced VJM in rats, whereas the classic AC-coupled D1-like site may subserve dopaminergic mediation of agonist-induced stereotypy and antagonist-induced catalepsy. Intraperitoneal administration of EEDQ reduced the maximum binding of dopamine D1-like receptors by approximately 75% in striatal tissue, thus indicating the receptor inactivating effect

Acknowledgements

This work was supported by the United States Public Health Service/National Institutes of Health (Grant# NS-35571).

References (39)

  • S.O. Ogren et al.

    The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors

    Neuroscience

    (1994)
  • D.R. Riddall

    A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo

    European Journal of Pharmacology

    (1992)
  • H. Rosengarten et al.

    A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats

    Biological Psychiatry

    (1998)
  • H. Rosengarten et al.

    A full repetitive jaw movement response after 70% depletion of caudate D1 receptors

    Pharmacology, Biochemistry and Behaviour

    (1989)
  • H. Rosengarten et al.

    A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats

    Pharmacology, Biochemistry and Behaviour

    (1993)
  • A.S. Undie

    Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation in brain slices

    Brain Research

    (1999)
  • A.S. Undie et al.

    Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain

    European Journal of Pharmacology

    (1992)
  • S.J. Boyson et al.

    Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain

    Journal of Neuroscience

    (1986)
  • C. Braestrup et al.

    Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site

    Journal of Neurochemistry

    (1987)
  • Cited by (35)

    • Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function

      2020, Pharmacological Research
      Citation Excerpt :

      However, Undieh [103] and his group were unable to replicate the findings in the absence of kynurenine, scopolamine, and glutathione, all of which were reported to be relevant for showing a dopamine or quinpirole blockade effect [102]. These agents have unpredictable effects on signaling events [100,104], as in the case of glutathione. Thus, it remains unclear if dopamine D2 receptor stimulation, on its own, can prevent basal or heterologous agonist-stimulated phosphoinositide hydrolysis.

    • Parkinson's Disease

      2017, Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood-Brain Barrier
    • Behavioral pharmacology of orofacial movement disorders

      2011, International Review of Neurobiology
      Citation Excerpt :

      These behavioral findings have led to the hypothesis that DA receptor-mediated jaw movements are mediated via mechanisms that differ from those involved in the acetylcholine receptor-mediated jaw movements. While D1-like receptors have been defined conventionally in terms of their linkage to the stimulation of adenylyl cyclase, neurochemical, neurophysiological and behavioral evidence indicates also the existence of a D1-like receptor coupled to a transduction system additional to adenylyl cyclase, with phosphoinositide hydrolysis being the most widely studied candidate (Mahan et al., 1990; Undie and Friedman, 1994; Undie et al., 1994, 2000; Waddington et al., 1995). However, any role for such a site at other levels of function is poorly understood.

    View all citing articles on Scopus
    View full text